Horizon Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Horizon Therapeutics is scheduled to report earnings on November 8, 2023, and the estimated EPS forecast is €1.11. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 944.96M	$ 832.06M	$ 942.03M	$ 925.36M	$ 876.41M
Gross Profit	$ 725.00M	$ 623.50M	$ 701.24M	$ 691.23M	$ 646.20M
EBIT	$ 135.25M	$ 19.20M	$ 107.71M	$ 157.56M	$ 86.20M
EBITDA	$ 232.84M	$ 115.53M	-	$ 256.64M	$ 183.62M
Net Income Common Stockholders	$ 127.07M	$ 54.68M	$ 120.34M	$ 135.84M	$ 60.97M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 2.47B	$ 2.32B	$ 2.36B	$ 2.16B	$ 1.89B
Total Assets	$ 9.30B	$ 8.99B	$ 9.11B	$ 9.03B	$ 8.85B
Total Debt	$ 2.56B	$ 2.56B	$ 2.56B	$ 2.57B	$ 2.57B
Net Debt	$ 88.04M	$ 243.83M	$ 205.25M	$ 409.51M	$ 674.43M
Total Liabilities	$ 3.99B	$ 3.90B	$ 9.11B	$ 3.99B	$ 3.91B
Stockholders Equity	$ 5.31B	$ 5.10B	$ 5.07B	$ 5.03B	$ 4.95B
Cash Flow	-
Free Cash Flow	$ 143.00M	$ 62.20M	$ 401.53M	$ 336.65M	$ 239.04M
Operating Cash Flow	$ 161.47M	$ 86.32M	$ 426.39M	$ 366.46M	$ 249.20M
Investing Cash Flow	$ -20.03M	$ -41.75M	$ -49.07M	$ -32.02M	$ -12.18M
Financing Cash Flow	$ 9.03M	$ -88.13M	$ -160.97M	$ -94.37M	$ 17.42M

Currency in USD

Horizon Therapeutics Earnings and Revenue History

Income Statement >

Horizon Therapeutics Debt to Assets

Balance Sheet >

Horizon Therapeutics Cash Flow

Cash Flow >

Horizon Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing